Last reviewed · How we verify
NCT05709990
Efficacy and Safety of High Dose Vitamin D Supplementation for Overactive Bladder Dry in Children
NA trial testing Solifenacin Succinate 5 MG Oral Tablet [Vesicare] in Overactive Bladder in 303 participants. Completed in 15 June 2023.
3 June 2023
Quick facts
| Lead sponsor | Xing Liu |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 303 |
| Start date | 15 January 2023 |
| Primary completion | 3 June 2023 |
| Estimated completion | 15 June 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- Solifenacin Succinate 5 MG Oral Tablet [Vesicare] — full drug profile →
- Vitamin D3 (cholecalciferol) — full drug profile →
- Standard urotherapy
Conditions studied
- Overactive Bladder — all drugs for Overactive Bladder →
Sponsor
Xing Liu — full company profile →
Who can join
Adults 5 to 18, any sex, with Overactive Bladder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This prospective, randomized, 3-arms, parallel-design, controlled clinical trial is conducted to determine whether high dose vitamin D supplementation (combined with standard urotherapy ) improves outcomes, compared with solifenacin (combined with standard urotherapy ) ,and standard urotherapy alone in children with OAB dry.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05709990
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Overactive Bladder
Currently open trials in the same condition.
- NCT06201013 — Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet · NA · recruiting
- NCT05895045 — Yoga for Treatment of Overactive Bladder in Pediatric Patients · NA · recruiting
- NCT07209397 — Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women · NA · recruiting
- NCT06921746 — Changes in the Urinary Microbiome and Metabolome During Treatment of the Overactive Bladder in Female Patients · recruiting
- NCT06935240 — Investigation of Effects of Electrical Stimulation in Women With Vaginal Laxity · NA · recruiting
Other Xing Liu trials
Trials by the same sponsor.
- NCT06520423 — Effectiveness of Urethral Stent Irrigation in Preventing Surgical Site Infections in Adolescents With Hypospadias · NA · active not recruiting
- NCT06489951 — Efficacy and Mechanism of High-Dose Vitamin D Supplementation in Pediatric OAB-Dry: A Randomized Clinical Trial Integrat · NA · completed
- NCT06508333 — Efficacy and Safety of Vitamin D Supplementation Combined With Alarm Therapy in Treating Nocturnal Enuresis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05709990 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Xing Liu
- Last refreshed: 6 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05709990.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing